Body weight variation and control of cardiovascular risk factors in essential hypertension

Blood Pressure
Jose Maria PascualJosep Redon

Abstract

The objective was to assess the impact of weight changes on blood pressure (BP), lipids and glucose goals in a cohort of hypertensive subjects. Prospective follow-up. Hypertension clinic. 326 hypertensive non-diabetic subjects, 46% with metabolic syndrome (MS). Usual care treatment, which included diet, physical exercise and drugs prescribed when indicated. All patients were observed for up to 1 year. BP and low-density lipoprotein-cholesterol (LDL-C) goal were those in ESH/ESC and ATP III recommendations, respectively. The glucose goal was to delay progression to type 2 diabetes mellitus, or to achieve blood glucose <100 mg/dl for non-diabetics. According to body weight changes, patients were categorized using adjusted ROC curves models. Overall, there was a significant weight increment of 0.5 kg (95% CI 0.1-0.9 kg); 28 patients (8.6%) lost more than 5 kg, and only four (1.2%) lost more than 10 kg. BP, LDL-C and glucose goals were achieved in 56%, 78% and 61% of patients, respectively. To lose or not gain weight was an independent prognostic factor to achieve the BP goal in all the patients and the LDL goal in the presence of MS. For glucose control, being treated with beta-blockers and/or diuretics was a negative factor. In h...Continue Reading

References

Sep 6, 1986·British Medical Journal·J C PetrieM de Swiet
Jan 24, 1998·Annals of Internal Medicine·Z HuangG A Colditz
Mar 19, 1999·Journal of Internal Medicine·A O RantalaY A Kesäniemi
Nov 5, 1999·JAMA : the Journal of the American Medical Association·A MustW H Dietz
Mar 11, 2000·American Journal of Hypertension·W B Kannel
Feb 24, 2001·Annals of Internal Medicine·V J StevensUNKNOWN Trials for the Hypertension Prevention Research Group
Feb 28, 2001·Obesity Research·C D BrownM Horan
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Katherine M FlegalClifford L Johnson
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Kevin R FontaineDavid B Allison
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Sep 11, 2003·European Heart Journal·Guy De BackerUNKNOWN Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Nov 18, 2003·Diabetes, Obesity & Metabolism·E Bøg-HansenL Råstam
May 18, 2004·Journal of the American College of Cardiology·Giuseppe SchillaciElmo Mannarino
May 25, 2005·Journal of Internal Medicine·G MulèG Cerasola
Sep 23, 2008·Journal of Hypertension·Josep RedonUNKNOWN Scientific Council of the European Society of Hypertension

❮ Previous
Next ❯

Citations

Jun 2, 2011·International Journal of Hypertension·Joseph M PappachanRajagopalan Sriraman
Jun 5, 2012·The Journal of Nutrition, Health & Aging·Z JancsoI Rurik
Oct 19, 2016·Medicina clínica·Patricia Boned OmbuenaJosé María Pascual Izuel
Jun 2, 2020·Patient Education and Counseling·Heather P WhitleyJason M Parton
Jun 11, 2010·Current Opinion in Cardiology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.